Furiex Pharmaceuticals (FURX) Narrows Q1 Loss
Tweet
Share
E-mailGet Alerts FURX Hot Sheet
Join SI Premium – FREE
Furiex Pharmaceuticals (Nasdaq: FURX) reported Q1 loss of $0.87, versus ($1.45) last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- EquipmentShare.com Inc. (EQPT) Reports Q2 EPS of $0.18; Offers Guidance
- SeaStar Medical (ICU) Misses Q1 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
